We are celebrating a new milestone in New Zealand!

Melissa Gilbert our National Sales Manager, has commented on this recent achievement;

“It’s a great feeling knowing that already so many New Zealanders have benefited from this advanced post-surgical sinus dressing. As we continue to grow, It’s exciting to hear about how Chitogel is improving surgical outcomes and enhancing the patient experience.”

In 2016/2017 the Ministry of Health published procedural data that reported New Zealand has 3,677 FESS procedures annually.
Therefore we can estimate Chitogel is currently being used in about 13-15% of FESS procedures within its first year of having been launched in New Zealand.

That’s a lot of local patients who have been able to experience the benefits of Chitogel, and we look forward to sharing their experiences with you in the coming months.